In a new study, published in the journal Nature, researchers from EMBL Barcelona, the University of Texas, the University of Copenhagen, and The Scripps Research Institute have discovered human antibodies that can recognise and target some of the proteins that cause severe malaria. This breakthrough could pave the way for future vaccines or anti-malaria treatments...
A Dolomite Microfluidics’ set-up is helping researchers in the University of Manchester’s Division of Pharmacy and Optometry to enhance drug delivery. Dr Annalisa Tirella explained: “My background is bioengineering, where I gained expertise in biomaterials and fabrication techniques. At the beginning of my career, I focused my research on the design and manufacture of biomaterials to be used as in vitro models for tissue engineering and regenerative medicine applications...
Mar 11, 2019
Simple folded sheets of waxed paper could help bring affordable, reliable field tests for diseases such as malaria to remote parts of the developing world, scientists say. In a new paper published in thejournal Proceedings of the National Academy of Sciences,researchers from universities in Scotland and China, working together with the Ministry of Health in Uganda, describe for the first time how origami-style folded paper, prepared...
ScreenIn3D, a partner of AMSBIO, reports on the accolades it has received following the recent launch of its novel microfluidic cancer screening service. Combining the latest advances in microfluidics and 3D culture - the service uses an optimised screening platform targeted at improving anticancer drug treatment and accelerating development of new personalised medicine solutions. At the recent Miptec conference in Basle, Switzerland - ScreenIn3D was one of 60 global organisations invited to showcase its cutting-edge life science technologies....
The Pioneers of Miniaturization Lectureship 2017, sponsored by Dolomite Microfluidics and Lab on a Chip, has been awarded to Professor Aaron Wheeler in recognition of his contribution to digital microfluidics, a technique which involves manipulating of discrete microfluidic droplets on the surface of an array of electrodes coated with a hydrophobic insulator.
Professor Wheeler is the author of more than 100 peer-reviewed publications, and has been the Canada Research Chair of Bioanalytical Chemistry at the University of Toronto since 2005. He will receive a certificate, a $2,000 prize and the opportunity to present a short lecture at the 2017 MicroTAS conference, which runs from the 22nd to the 26th of October at the Savannah International Trade & Convention Center in Georgia, USA. All registered MicroTAS participants are invited...
Precision NanoSystems NanoAssemblr™ platform has been selected for the controlled manufacture of nanomedicines as part of the multinational B-SMART (Brain-Specific, Modular and Active RNA Therapeutics) translational research project.
This €6 million initiative, funded by the EU Horizon 2020 program, aims to use RNA-based therapeutics to silence the production of disease-causing proteins for a range of neurodegenerative disorders, such as Parkinson’s, Alzheimer’s and Huntington’s. Professor Raymond Schiffelers from UMC Utrecht is leading the project, and explained its goals....
Analytik, leading suppliers of innovative analytical instrumentation, announce the availability of Microfluidics’ new LM20 high shear fluid processor.
Microfluidics, part of IDEX Corporation, is the manufacturer of unique high shear fluid processors, known as Microfluidizers, that can produce dispersions & emulsions of very tight particle size distributions, effectively de-agglomerate particles and disrupt cells in suspension. The new LM20 Microfluidizer® is a digitally controlled high-shear fluid processor capable of processing from 14 ml batches up to 100 ml/minute continuously. A first for a...
A Nano Approach for ELA 2012
Apr 13, 2012Select Biosciences, organisers of European Lab Automation (ELA) 2012, is pleased to announce that a new conference stream, dedicated to the issues and technologies associated with the rapidly developing Nano and Microfluidics field, will form one of the eight topical conference streams. The use of nano and microfluidics has greatly expanded over the last few years, and this stream aims to provide delegates with an overview of the field, with talks on the advances in microfabrication and applications of nano and microfluidics...
European Lab Automation 2012
Jan 20, 2012Staying abreast of the latest advances in technology and ensuring that the most effective, up-to-date automation techniques are being employed can be challenging. Attending conferences and exhibitions throughout the year provides scientists not only with the opportunity to share their experiences, but with face-to-face networking opportunities; delegates can discuss their challenges with equipment manufacturers who can often help to tailor a solution to meet their automation needs. The debut of the European Laboratory Automation (ELA) conference and exhibition in June 2011 attracted 1523 attendees as well as 151 exhibitors and media partners. ELA combined...
Select Biosciences Gears Up for ELA 2012
Nov 8, 2011Following the success of European Laboratory Automation (ELA) 2011, Select Biosciences has announced that it will be hosting next year's conference and exhibition at the Congress Centre Hamburg (CCH), Germany, 30 - 31 May 2012. Registration for ELA 2012 is now open, and all delegates have the option to attend 8 different conference streams, each of which includes internationally renowned keynote speakers, research presentations, training sessions and much more...
Microfluidics Achieves ISO 9001:2008 Certification
Mar 7, 2011Microfluidics International Corporation announced that its Quality Management System has achieved ISO 9001:2008 certification. The certification verifies that Microfluidics has effectively applied the ISO 9001 standard to the design, manufacture and distribution of Microfluidizer® high shear fluid processors for pharmaceutical, biotechnology, chemical and allied industries...
In a new study, published in the journal Nature, researchers from EMBL Barcelona, the University of Texas, the University of Copenhagen, and The Scripps Research Institute have discovered human antibodies that can recognise and target some of the proteins that cause severe malaria. This breakthrough could pave the way for future vaccines or anti-malaria treatments...
A Dolomite Microfluidics’ set-up is helping researchers in the University of Manchester’s Division of Pharmacy and Optometry to enhance drug delivery. Dr Annalisa Tirella explained: “My background is bioengineering, where I gained expertise in biomaterials and fabrication techniques. At the beginning of my career, I focused my research on the design and manufacture of biomaterials to be used as in vitro models for tissue engineering and regenerative medicine applications...
ScreenIn3D, a partner of AMSBIO, reports on the accolades it has received following the recent launch of its novel microfluidic cancer screening service. Combining the latest advances in microfluidics and 3D culture - the service uses an optimised screening platform targeted at improving anticancer drug treatment and accelerating development of new personalised medicine solutions. At the recent Miptec conference in Basle, Switzerland - ScreenIn3D was one of 60 global organisations invited to showcase its cutting-edge life science technologies....
Professor Wheeler is the author of more than 100 peer-reviewed publications, and has been the Canada Research Chair of Bioanalytical Chemistry at the University of Toronto since 2005. He will receive a certificate, a $2,000 prize and the opportunity to present a short lecture at the 2017 MicroTAS conference, which runs from the 22nd to the 26th of October at the Savannah International Trade & Convention Center in Georgia, USA. All registered MicroTAS participants are invited...
Microfluidics, part of IDEX Corporation, is the manufacturer of unique high shear fluid processors, known as Microfluidizers, that can produce dispersions & emulsions of very tight particle size distributions, effectively de-agglomerate particles and disrupt cells in suspension. The new LM20 Microfluidizer® is a digitally controlled high-shear fluid processor capable of processing from 14 ml batches up to 100 ml/minute continuously. A first for a...
Select Biosciences, organisers of European Lab Automation (ELA) 2012, is pleased to announce that a new conference stream, dedicated to the issues and technologies associated with the rapidly developing Nano and Microfluidics field, will form one of the eight topical conference streams. The use of nano and microfluidics has greatly expanded over the last few years, and this stream aims to provide delegates with an overview of the field, with talks on the advances in microfabrication and applications of nano and microfluidics...
Following the success of European Laboratory Automation (ELA) 2011, Select Biosciences has announced that it will be hosting next year's conference and exhibition at the Congress Centre Hamburg (CCH), Germany, 30 - 31 May 2012. Registration for ELA 2012 is now open, and all delegates have the option to attend 8 different conference streams, each of which includes internationally renowned keynote speakers, research presentations, training sessions and much more...
Microfluidics International Corporation announced that its Quality Management System has achieved ISO 9001:2008 certification. The certification verifies that Microfluidics has effectively applied the ISO 9001 standard to the design, manufacture and distribution of Microfluidizer® high shear fluid processors for pharmaceutical, biotechnology, chemical and allied industries...